• Home
  • Market
  • Sun Pharma Shares: Expert Dharmesh Shah from ICICI Securities Recommends Buy on May 12, 2025!
Sun Pharma Shares: Expert Dharmesh Shah from ICICI Securities Recommends Buy on May 12, 2025!

Sun Pharma Shares: Expert Dharmesh Shah from ICICI Securities Recommends Buy on May 12, 2025!

As we step into the upcoming week, the Indian stock market is set to navigate a complex landscape shaped by geopolitical events, particularly the escalating tensions with Pakistan. Analysts predict that macroeconomic indicators and corporate earnings will also play a crucial role in market movements. The Nifty 50 index concluded the week at 24,008.00, reflecting a decline of 1.39%, while the Sensex ended at 79,454.47, down 1.30%.

Market Reactions to Geopolitical Tensions

The recent decline in stock indices can largely be attributed to heightened geopolitical tensions, particularly following reports of drone and missile strikes. The Indian Army’s announcement regarding these attacks has left investors cautious, prompting a sell-off on the final trading day of the week.

  • Foreign Institutional Investors (FIIs) offloaded shares worth a staggering ₹3,798 crores on May 9 amid rising conflict concerns.
  • Despite the current ceasefire, experts suggest that FIIs may soon consider re-entering the Indian market as stability returns.

Projections for the Nifty 50

According to Dharmesh Shah, Vice President at ICICI Securities, the Nifty 50 is expected to stabilize within a range of 24,500-23,200 during the ongoing earnings season. He emphasizes that stock-specific movements will dominate the market:

  • The market has formed a bear candle, suggesting a pause after three weeks of significant upward movement.
  • India’s VIX index reached its highest weekly close since June 2024 at 21.54, indicating increased market uncertainty.

Economic Indicators and Market Sentiment

The Indian rupee also experienced volatility, closing the week at 85.46 against the dollar. Various sectors displayed mixed performances, with the auto sector showing resilience while the real estate and PSU banks faced downward pressure.

See also  Top Stock Picks for 2023: Macquarie's Bottom-Up Buys Featuring HDFC Bank, TCS, Sun Pharma, NTPC, and Wipro

Key Factors Influencing Market Behavior:

  • Historical data suggests that previous armed conflicts, like the Kargil War and the Pulwama attack, led to significant market recoveries once initial anxieties subsided.
  • Market experts believe that the current geopolitical climate, while tense, may not lead to prolonged downturns. They advocate for a measured approach to portfolio building.

Strategic Insights for Investors

Shah encourages investors to stay composed and consider quality stocks for medium to long-term gains during this earnings season.

Factors Supporting Market Recovery:

  1. Continuous inflow from Foreign Institutional Investors (FIIs)
  2. Progress in trade agreements, including the India-UK Free Trade Agreement
  3. Bilateral agreements with the United States
  4. A potential decline in the US Dollar index and Brent crude oil prices

Stock Recommendations for the Week

In light of current market conditions, Dharmesh Shah recommends purchasing shares of Sun Pharmaceutical Industries within a price range of ₹1,780 – ₹1,833. He projects a target price of ₹2,040 with a suggested stop-loss at ₹1,687.

As we look ahead, investors are advised to keep a close watch on geopolitical developments while strategically building resilient portfolios that can weather potential market fluctuations.

For more insights and stock recommendations, stay tuned to our updates on the Indian stock market trends.

Related Post

IREDA Takes Legal Action: Insolvency Petition Filed Against Gensol Engineering for ₹510 Crore Default
IREDA Takes Legal Action: Insolvency Petition Filed Against Gensol Engineering for ₹510 Crore Default
ByAbhinandanMay 15, 2025

The Indian Renewable Energy Development Agency (IREDA) has filed for insolvency against Gensol Engineering over…

JB Chemicals & Pharmaceuticals Q4 Highlights: Profit and Revenue Align with Market Expectations!
JB Chemicals & Pharmaceuticals Q4 Highlights: Profit and Revenue Align with Market Expectations!
ByAbhinandanMay 14, 2025

JB Chemicals & Pharmaceuticals Ltd. reported a 16% increase in consolidated net profit for Q4…

FPIs Shift Gears: Emerging as Net Buyers After One Day of Activity!
FPIs Shift Gears: Emerging as Net Buyers After One Day of Activity!
ByAbhinandanMay 14, 2025

On Wednesday, foreign portfolio investors (FPIs) returned to the Indian equity market, purchasing shares worth…

Apollo Tyres Q4 Earnings: Profit Decline Driven by Exceptional Losses
Apollo Tyres Q4 Earnings: Profit Decline Driven by Exceptional Losses
ByAbhinandanMay 14, 2025

Apollo Tyres Ltd. reported a 48% decline in consolidated net profit for Q4 FY2025, totaling…

Leave a Reply

Your email address will not be published. Required fields are marked *

JOIN US

Get Newsletter

Subscribe our newsletter to get the best stories into your inbox!